Moreover, the DIM-3,5 ligands also decrease PD-L1 expression [20], and enhance CD8+/CD4 + T cell ratios in tumor infiltrating lymphocytes in a syngeneic orthotopic mouse model of breast cancer [18, 19]. The gene discussed is CD274; the disease is breast cancer.